Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Depreciation & Amortization (CF): 2015-2024

Historic Depreciation & Amortization (CF) for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $606,000.

  • Anaptysbio's Depreciation & Amortization (CF) fell 2.78% to $140,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $573,000, marking a year-over-year decrease of 8.47%. This contributed to the annual value of $606,000 for FY2024, which is 7.06% down from last year.
  • Anaptysbio's Depreciation & Amortization (CF) amounted to $606,000 in FY2024, which was down 7.06% from $652,000 recorded in FY2023.
  • In the past 5 years, Anaptysbio's Depreciation & Amortization (CF) registered a high of $675,000 during FY2022, and its lowest value of $559,000 during FY2020.
  • In the last 3 years, Anaptysbio's Depreciation & Amortization (CF) had a median value of $652,000 in 2023 and averaged $644,333.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first rose by 10.73% in 2021, then fell by 7.06% in 2024.
  • Yearly analysis of 5 years shows Anaptysbio's Depreciation & Amortization (CF) stood at $559,000 in 2020, then climbed by 10.73% to $619,000 in 2021, then grew by 9.05% to $675,000 in 2022, then dropped by 3.41% to $652,000 in 2023, then dropped by 7.06% to $606,000 in 2024.